| Application no. and date | 17157697.8 (espacenet) (Federated) (European Patent Register), 20100329 | | Patent/reg. no. and date | DK/EP 3222277, 20200226 | | Publication date | 20170927 | | Priority no. and date | US 165447 P, 20090331, US 165419 P, 20090331 | | EP pub. no. and date |
EP 3222277 20170927 | | Effective date | | | Applicant/owner | Ligand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121, US | | Applicant ref. no. | V47707DK00 | | Inventor | Zhang, Jinkun, 11496 Tree Hollow Lane
San Diego, CA California 92128, US,
Dziewanowska, Zofia E, 765 Bonair Place
La Jolla, CA California 92037, US,
Belder, Rene, 579 Province Line Road
Hopewell, NJ New Jersey 08525, US,
Bogardus, Joseph B, 892 Hurricane Road
Keene, NY New York 12942, US,
Henderson, Ian, 5220 Fiore Terrace, No 405
San Diego, CA California 92122, US,
Zhang, Zhaoying, 20 El Dorado Way
Monroe, NJ New Jersey 08831, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/422 (2006.01) , A61K 9/20 (2006.01) , A61P 13/12 (2006.01) , A61P 9/12 (2006.01) | | Title | Biphenylsulfonamidendothelin- og angiotensin II-receptorantagonist til behandling af glomerulosklerose og IgA-induceret nefropati | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2024 00036 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
